Skip to content
value.today

AbbVie Inc. vs Johnson & Johnson

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $514.0 B for AbbVie Inc., 1.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 29, 2026 for Johnson & Johnson).
  • Johnson & Johnson had more revenue: $94.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025.
  • Johnson & Johnson earned more: net income of $26.8 B against $4.2 B for AbbVie Inc.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 6.9% for AbbVie Inc.
  • Johnson & Johnson employs more people: 138,200 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $681,570 at Johnson & Johnson.
  • On price to earnings, AbbVie Inc. trades at 49.7× and Johnson & Johnson at 40.5×: investors pay more for each dollar of AbbVie Inc.'s profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0981952933902020202120222023202420252026AbbVie Inc. 390Johnson & Johnson 170

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B201720182019202020212022202320242025AbbVie Inc. $61BJohnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Johnson & Johnson
JNJ · #23 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20131886
Size
Market cap$514.0 B$652.5 B
Revenue$61.2 B$94.2 B
Net income$4.2 B$26.8 B▲ best
Employees57,000138,200
Valuation
P/E ratio49.7×40.5×
Price to sales7.8×6.6×
Price to book—8.0×
Free cash flow yield3.5%▲ best3.0%
Profitability
Gross margin70.2%—
Operating margin24.6%—
Net margin6.9%—
Return on invested capital16.0%—
Growth
Revenue growth8.6%—
Revenue growth, 3 years a year1.8%—
Earnings per share growth-1.3%—
Financial strength
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Johnson & Johnson?

Johnson & Johnson is the larger company by market value: $652.5 B against $514.0 B for AbbVie Inc., 1.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 29, 2026 for Johnson & Johnson).

Which makes more money, AbbVie Inc. or Johnson & Johnson?

Johnson & Johnson had more revenue: $94.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025. Johnson & Johnson earned more: net income of $26.8 B against $4.2 B for AbbVie Inc.

Which is more profitable, AbbVie Inc. or Johnson & Johnson?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 6.9% for AbbVie Inc.

Which has more employees, AbbVie Inc. or Johnson & Johnson?

Johnson & Johnson employs more people: 138,200 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $681,570 at Johnson & Johnson.

Is AbbVie Inc. cheaper than Johnson & Johnson?

On price to earnings, AbbVie Inc. trades at 49.7× and Johnson & Johnson at 40.5×: investors pay more for each dollar of AbbVie Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Sources#

Every figure on this page comes from these, with the date shown next to it.